PECAM-1通过Wnt/β-catenin信号通路介导肺血管内皮通透性改变在SARS-CoV-2相关ARDS中的作用及分子机制
批准号:
82070084
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
刘晓青
依托单位:
学科分类:
急性肺损伤和急性呼吸窘迫综合征
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
刘晓青
中文摘要
新型冠状病毒(SARS-CoV-2)传染性高,致病性强。重症患者常合并ARDS,病死率高。SARS-CoV-2相关ARDS发病机理尚未阐明。我们研究发现此类患者肺泡死腔增加,提示可能存在肺血管内皮损伤导致肺的微循环障碍,并得到国际同行认可。血小板内皮细胞黏附分子(PECAM-1)是维持血管内皮细胞完整性的重要结构基础,它与β-catenin结合形成复合物组成细胞骨架,在调节血管通透性方面发挥着重要作用。本课题拟通过体外实验新冠病毒刺激人肺微血管内皮细胞和体内构建新冠病毒相关ARDS动物模型结合临床研究,利用RT-PCR、免疫荧光、免疫印迹及腺病毒质粒转载等方法,探讨新冠病毒对肺微血管内皮细胞通透性的影响,阐释PECAM-1通过Wnt/β-catenin通路介导肺血管通透性改变在SARS-CoV-2相关ARDS中的作用及机制。本研究结果为有效防治新冠病毒相关ARDS提供科学依据及药物新靶点。
英文摘要
A novel coronavirus, severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) has spread rapidly around the world and caused severe illness and death. The critically ill patients often develop Acute Respiratory Distress Syndrome (ARDS), leading to a high mortality. Unfortunately, the mechanism underlying SARS-CoV-2 related ARDS remains largely unknown. We have previously demonstrated that increased alveolar dead space is common in COVID-19 associated ARDS patients, suggesting that pulmonary vascular endothelial damage may exit that leads to pulmonary microcirculation disorders. Platelet endothelial cell adhesion molecule (PECAM-1) is an important structural basis for maintaining the integrity of vascular endothelial cells. It combines with β-catenin to form a complex that constitutes a cytoskeletal component and plays an important role in regulating microvascular permeability. Here, we propose to establish an in vitro SARS-CoV-2 related ARDS model through SARS-CoV-2 infected human lung microvascular endothelial cells and an in vivo SARS-CoV-2 infected animal model. In addition, clinical specimen from SARS-CoV-2 related ARDS will be collected and studied as well. RT-PCR, immunofluorescence and Western blotting and adenovirus plasmid transfer technic methods will be performed to explore the effect of SARS-CoV-2 on the permeability change of pulmonary microvascular endothelial cells and the expression of PECAM-1, further explaining the mechanism of PECAM-1 in mediating pulmonary vascular permeability change through the Wnt / β-catenin signaling pathway in SARS CoV-2 related ARDS. The study will provide a potential target for SARS-CoV-2 related ARDS.
重症新型冠状病毒感染患者常合并ARDS,病死率高。SARS-CoV-2相关ARDS发病机理尚未阐明。深入研究SARS-CoV-2相关ARDS发病机制有助于明确SARS-CoV-2相关ARDS发生的分子机制。我们前期研究发现此类患者肺泡死腔增加,提示可能存在肺血管内皮损伤导致肺的微循环障碍,并得到国际同行认可。血小板内皮细胞黏附分子(PECAM-1) 是维持血管内皮细胞完整性的重要结构基础,它与β-catenin结合形成复合物组成细胞骨架,在调节血管通透性方面发挥着重要作用。在本项目资助下,项目负责人按照研究计划开展研究工作并取得系列研究成果:1、成功构建了体外SARS-CoV-2感染人肺微血管内皮细胞模型;2、明确SARS-CoV-2原始株感染能感染人肺微血管内皮细胞;3、SARS-CoV-2感染可引起人肺微血管内皮细胞PECAM-1表达下降;4、SARS-CoV-2原始株感染能使人肺微血管内皮细胞通透性增加;5、SARS-CoV-2原始株感染能使人肺微血管内皮细胞Wnt/β-catenin信号通路相关蛋白表达下降;6、SARS-CoV-2 WT感染所致的ARDS患者血浆中可溶性PECAM-1(sPECAM-1)水平明显高于健康患者。研究初步探讨了PECAM-1可介导肺血管通透性改变及其在SARS-CoV-2相关ARDS中的作用及潜在分子机制。本项目共发表SCI收录文章6篇,发表中文核心期刊文章2篇。项目负责人参与相关专家共识2项,获得实用新型专利一项,外观设计专利一项。通过本项研究我们初步探讨了SARS-CoV-2原始株感染对人肺微血管内皮细胞通透性的影响及可能的分子机制,阐明了PECAM-1在SARS -CoV-2相关ARDS的作用及可能机制,为有效防治新冠病毒相关ARDS提供科学依据及药物新靶点。
国内基金
海外基金